
Docetaxel Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 20 mg/0.5 mL, 80 mg/2 mL, 160 mg/4 mL
Reference Brands: Taxotere® (US & EU), Docefrez® (EU)
Category: Oncology Cancer Care
Docetaxel is available in Injection and strengths such as 20 mg/0.5 mL, 80 mg/2 mL, 160 mg/4 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Docetaxel is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Docetaxel can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Docetaxel Injection is a widely used cytotoxic chemotherapy drug indicated for breast, lung, prostate, gastric, and head & neck cancers. We offer Docetaxel in EU-GMP and USFDA-compliant injectable formulations, including 20 mg, 80 mg, and 160 mg single-use vials. Available for B2B supply, contract manufacturing, and licensing, our Docetaxel meets global regulatory standards with full CTD dossiers and stability data. Alcohol-free and solvent-based options are available. Ideal for distributors, hospitals, and procurement agencies seeking high-quality oncology products. Partner with us for reliable Docetaxel bulk supply or private label opportunities across Europe, the US, and emerging regulated markets.
Frequently Asked Questions
Related Products
Atezolizumab
Strength:
1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View DetailsDurvalumab
Strength:
120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View DetailsSunitinib
Strength:
12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers